Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?

  • 1,
  • 2,
  • 3,
  • 4 and
  • 5
Pediatric Rheumatology20086 (Suppl 1) :P4

  • Published:


  • Arthritis
  • Comparable Test
  • Juvenile Idiopathic Arthritis
  • Uveitis
  • Risk Stratification


Antihistone antibodies (AHA) are an ANA subtype reported to be associated with uveitis in Juvenile idiopathic arthritis (JIA). Enzyme-linked immunoassays (E-ANA) are increasingly used as a more standardized alternative to the immunofluorescense method on Hep-2 cells (IF-ANA). E-ANA, however, show no association with uveitis and should not be used in the diagnostic work-up of JIA.

Materials and methods

Sera of 100 children with JIA and 60 healthy children were analyzed for antihistone IgM/IgG (Pharmacia ELIA kit), for E-ANA and IF-ANA. Patients were recruited prospectively and followed at regular intervals from onset of disease in 1997–2004.


Of the 100 children with JIA, 16 developed asymptomatic chronic uveitis; mean observation time was seven years. Antihistone IgM/IgG > 30 U/ml were found in six of the 100 children with JIA, four of whom developed uveitis, and in one of the controls. However, exploring lower cut-off levels of AHA, we found uveitis in 13 of 44 patients with AHA > 8 U/ml. Analyses of predictors for uveitis show that young age at onset of arthritis, AHA > 8 U/ml and IF-ANA titer > 1/320 carry significantly increased risk of developing uveitis. No significant increased risk is found for the oligoarthritis subtype, female gender, positive E-ANA and IF-ANA titer > 1/80.


Antihistone IgM/IgG are significantly associated with uveitis in JIA children. AHA at a low cut-off level, show comparable test performance as IF-ANA, in predicting uveitis. As E-ANA replaces IF-ANA in many laboratories, further studies are needed to confirm the value of the AHA in risk stratification for uveitis screening.

Authors’ Affiliations

Department of Pediatrics, University Hospital of North Norway and Institute of Community Medicine, University of Tromsø, Tromsø, Norway
Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway
Institute of Community Medicine, University of Tromsø, Tromsø, Norway
Department of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden
Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology and Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway


© Nordal et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.